Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Work In Process (2020 - 2025)

IceCure Medical has reported Work In Process over the past 6 years, most recently at $271000.0 for Q4 2025.

  • For Q4 2025, Work In Process rose 17.32% year-over-year to $271000.0; the TTM value through Dec 2025 reached $271000.0, up 17.32%, while the annual FY2025 figure was $271000.0, 17.32% up from the prior year.
  • Work In Process was $271000.0 for Q4 2025 at IceCure Medical, up from $231000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $457000.0 in Q4 2021 and bottomed at $231000.0 in Q4 2024.
  • The 5-year median for Work In Process is $316000.0 (2023), against an average of $326200.0.
  • Year-over-year, Work In Process skyrocketed 37.65% in 2021 and then decreased 26.9% in 2024.
  • Over 5 years, Work In Process stood at $457000.0 in 2021, then dropped by 22.1% to $356000.0 in 2022, then fell by 11.24% to $316000.0 in 2023, then decreased by 26.9% to $231000.0 in 2024, then rose by 17.32% to $271000.0 in 2025.
  • The last three reported values for Work In Process were $271000.0 (Q4 2025), $231000.0 (Q4 2024), and $316000.0 (Q4 2023) per Business Quant data.